Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by M. Bailey
PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Robert Zirkelbach, chief public affairs officer at PhRMA, said the 340B Drug Pricing Program has changed dramatically over the past decade, with nearly two-thirds of U.S. pharmacies now participating and little transparency into how patients actually benefit. "The 340B program has changed dramatically over the past decade," said Zirkelbach on X. "Today, nearly two-thirds of U.S. pharmacies participate in 340B, yet there's little transparency into how patients benefit.
Prospective biomarkers of posttraumatic stress disorder in children and adolescents: a systematic review and meta-analysis
Abstract Trauma exposure in children and young people (CYP) can lead to the development of posttraumatic stress disorder (PTSD). Identification of biomarkers prospectively associated with PTSD can provide critical insight into the mechanisms underpinning this disorder and potentially aid in identifying CYP vulnerable to persistent symptoms.
Midland County Sheriff’s Reports, Jan. 1
MIDLAND COUNTY SHERIFF'S OFFICE Media Arrest Summary, by Name ARMENDARIZ, JOCELYNN G Booking Number: 372651 Inmate Number: 118207 Name Number: 468721 Age: 24 Address: 1508 N SAINT GALL ST, FORT STOCKTON, TX Arrest Type: CUST Arrested By: OCAMPO M Agency: MCSO Arrest Location: 12504 WHY 1941 Arrest Number: 392590 Related Incidents: 24-00019 Time/Date Offense Area Statute Court Crime Class 03:43:00 01/01/24 PUBLIC INTOXICATION 42.08-A JP1 MC BAILEY, RAEHA Booking Number: 372670 Inmate Number:...
PHL’s Office of Business Diversity’s Active and Winning Summer of 2021
September 21 2021 Written By: M. Denise Bailey While COVID-19 had wide-ranging impacts on the airline industry, Philadelphia International Airport's (PHL) Office of Business Diversity (OBD) honored its commitments, spearheaded new initiatives, and were recognized for its efforts. At the helm of PHL’s OBD is Kathleen Padilla, Deputy Director of Diversity and Inclusion.
A pilot multicentre randomised controlled trial of lidocaine infusion in women undergoing breast cancer surgery
Summary Chronic postoperative pain is common after breast cancer surgery. Peri-operative lidocaine infusion may prevent the development of chronic postoperative pain, but a large-scale trial is required to test this hypothesis. It is unclear whether a pragmatic, multicentre trial design that is consistent with expert guidance, addresses the limitations of previous studies, and overcomes existing translational barriers is safe, effective and feasible.
An analysis on fit-testing of Respiratory Protective equipment in the UK during the initial response to the Covid-19 pandemic
SUMMARY Background Public Health England guidance stipulates the use of filtering facepiece (FFP3) masks for healthcare workers engaged in aerosol-generating procedures. Mask fit-testing of respiratory protective equipment is essential to protect healthcare workers from aerosolized particles. Aim To analyse the outcome of mask fit-testing across National Health Service (NHS) hospitals in the UK during the first wave of the coronavirus disease 2019 (COVID-19) pandemic.
Modelling the growth of popliteal artery aneurysms
Original article H. Shiwani Corresponding Author E-mail address: hshiwani@gmail.com http://orcid.org/0000-0002-0046-2884 Department of Radiology, Leeds General Infirmary, Leeds, UK Leeds Vascular Institute, Leeds General Infirmary, Leeds, UK Correspondence to: Dr H. Shiwani, Department of Radiology, Leeds General Infirmary, Great George Street, Leeds LS1 3EX, UK (e‐mail: hshiwani@gmail.com)Search for more papers by this author Get access to the full version of this article.
The safety and efficacy of neuromodulation using percutaneous electrical nerve stimulation for the management of trigeminal‐mediated headshaking in 168 horses
Introduction Trigeminal‐mediated headshaking is an idiopathic neuropathic facial pain condition of the horse. The condition can have important welfare implications 1. It carries a poor prognosis, with published treatments lacking consistent efficacy, and in some instances, safety and practical application 2-5. The use of a nose‐net improves clinical signs by 70% or greater in one‐third of horses 6.
Chemotherapy-induced neuroinflammation is associated with disrupted colonic and bacterial homeostasis in female mice
Abstract Chemotherapy treatment negatively affects the nervous and immune systems and alters gastrointestinal function and microbial composition. Outside of the cancer field, alterations in commensal bacteria and immune function have been implicated in behavioral deficits; however, the extent to which intestinal changes are related to chemotherapy-associated behavioral comorbidities is not yet known.
Author Correction: Insights into Pasteurellaceae carriage dynamics in the nasal passages of healthy beef calves
Correction to: Scientific Reports https://doi.org/10.1038/s41598-019-48007-5, published online 16 August 2019 The Acknowledgements section in this Article is incomplete.
The safety and efficacy of neuromodulation using percutaneous electrical nerve stimulation for the management of trigeminal‐mediated headshaking in 168 horses - Roberts - - Equine Veterinary Journal - Wiley Online Library
General Article The safety and efficacy of neuromodulation using percutaneous electrical nerve stimulation for the management of trigeminal‐mediated headshaking in 168 horses This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record.
The safety and efficacy of neuromodulation using percutaneous electrical nerve stimulation for the management of trigeminal‐mediated headshaking in 168 horses - Roberts - - Equine Veterinary Journal - Wiley Online Library
General Article The safety and efficacy of neuromodulation using percutaneous electrical nerve stimulation for the management of trigeminal‐mediated headshaking in 168 horses This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record.
The safety and efficacy of neuromodulation using percutaneous electrical nerve stimulation for the management of trigeminal‐mediated headshaking in 168 horses
Summary Background Early results from the use of neuromodulation by percutaneous electrical nerve stimulation for the management of trigeminal‐mediated headshaking in horses were promising but lacked sufficient case numbers and long‐term follow‐up. The neuromodulatory procedure has since been established as EquiPENS™. Objectives The aim of this study was to report long‐term results from a larger number of cases and to investigate for predictors of outcome.
Modelling the growth of popliteal artery aneurysms
Popliteal artery aneurysms (PAAs) comprise up to 85 per cent of all peripheral aneurysms. Few longitudinal studies track their progression. This study aimed to track the growth of asymptomatic PAAs in a hospital‐based ultrasound service, and compare models of aneurysm growth. This retrospective single‐centre cohort study included patients who had a PAA on arterial duplex ultrasound imaging of the lower limbs between 1 January 2011 and 1 January 2016.
Modelling the growth of popliteal artery aneurysms
Popliteal artery aneurysms (PAAs) comprise up to 85 per cent of all peripheral aneurysms. Few longitudinal studies track their progression. This study aimed to track the growth of asymptomatic PAAs in a hospital‐based ultrasound service, and compare models of aneurysm growth. This retrospective single‐centre cohort study included patients who had a PAA on arterial duplex ultrasound imaging of the lower limbs between 1 January 2011 and 1 January 2016.
Small cell lung carcinoma harbors targetable alterations including MYCL1 fusions responding to aurora kinase inhibitor
Small cell lung carcinoma harbors targetable alterations including MYCL1 fusions responding to aurora kinase inhibitor S. Ali1, B. Kolla2, M. Bailey1, A.B. Schrock3, S.J. Klempner4, G.M. Frampton5, D.A. Fabrizio6, S-H.I. Ou7, J. He8, J. Suh9, J.S. Ross10, P. Stephens11, V. Miller1 and M.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with M.
Contact M., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack